<DOC>
	<DOCNO>NCT01703091</DOCNO>
	<brief_summary>The purpose study evaluate effect ramucirumab combination docetaxel participant Stage IV non-small cell lung cancer disease progression one prior first-line platinum-based chemotherapy without maintenance therapy advanced/metastatic disease .</brief_summary>
	<brief_title>A Study Docetaxel Ramucirumab Versus Docetaxel Placebo Treatment Stage IV Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Ramucirumab</mesh_term>
	<criteria>NonSmall Cell Lung Cancer disease Clinical stage IV recurrent disease One prior firstline platinumbased chemotherapy regimen without maintenance therapy For NonSmall Cell Lung Cancer ( NSCLC ) tumor squamous cell histology , epidermal growth factor receptor ( EGFR ) mutation status know prior randomization For participant activate epidermal growth factor receptor ( EGFR ) mutation , prior epidermal growth factor receptor tyrosine kinase inhibitor ( EGFRTKI ) monotherapy ( one regimen set single use ) utilized Eastern Cooperative Oncology Group ( ECOG ) Performance Status ( PS ) 0 1 Measurable disease define Response Evaluation Criteria Solid Tumors ( RECIST ) version RECIST version 1.1 Adequate organ function Estimated life expectancy least 3 month . Have undergone major surgery within 28 day prior randomization plan major surgery study treatment Receiving concurrent treatment anticancer therapy Central nervous system disease stable treat brain metastasis Has major blood vessel invasion encasement cancer Has intratumor cavitation Has history uncontrolled thrombotic disorder Is receive therapeutic anticoagulation drug Is receive chronic therapy nonsteroidal antiinflammatory drug Has history hemoptysis within 2 month prior randomization Has clinically relevant congestive heart failure Has experience arterial thromboembolic event Has uncontrolled arterial hypertension Has serious nonhealing wound , ulcer Has significant exist condition</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>